http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H04275212-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e17ac3e790b960c8a589610fa3d767e6
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2800-92
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q11-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-662
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-29
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-34
filingDate 1991-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b133c4285772339b68e11c2156b2852
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_95bca5fa7fdde2a9dbe1a92340c2b635
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b4594cf4283ee458fc09f5eea1ccc37
publicationDate 1992-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H04275212-A
titleOfInvention Anticalculus oral composition
abstract PURPOSE: To more effectively inhibit action of saliva enzyme on anticalculus agent of polyphosphoric acid by using a non-polycarboxylate polymer. n CONSTITUTION: This oral composition such as toothpaste (including gel or cream), mouthwash, lozenge, chewing gum or tooth powder comprises a calculus- inhibiting amount of a linear molecularly dehydrated polyphosphate salt and a synthetic polymeric vinyl phosphate as inhibitor of enzymatic hydrolysis of the polyphosphate salt in saliva. A fluorine ion-providing source may also be present to further inhibit enzymatic hydrolysis of the polyphosphate salt. n COPYRIGHT: (C)1992,JPO
priorityDate 1990-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135020
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415830335
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13766261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14917
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559562
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226471042

Total number of triples: 37.